Kevin McMullen, MD
Radiation Oncology · Statesville, NCNPI 1093797045
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,091 of the $26,168 with a category attached, or 95.9%. QT Imaging, Inc. accounts for 96.5% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $14,636 and has fallen 99.6% since, to $59 in 2025. Among radiation oncology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $368.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QT Imaging, Inc.$25K
- Amgen$135
- Bayer$72
- Bristol Myers Squibb$66
- AstraZeneca$63
- Clovis Oncology, Inc.$57
- plus $518 from 19 others
What the payments were for
- Consulting fees$25,09196%
- Food & beverage$1,0784%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QT Imaging, Inc. | 12 | $25,257 |
| Amgen | 8 | $135 |
| Bayer | 5 | $72 |
| Bristol Myers Squibb | 4 | $66 |
| AstraZeneca | 4 | $63 |
| Clovis Oncology, Inc. | 4 | $57 |
| Daiichi Sankyo Inc. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 4 | $55 |
| Eisai Inc. | 4 | $54 |
| Novocure Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $39 |
| Teleflex LLC | 1 | $37 |
| Portola Pharmaceuticals, LLC | 2 | $29 |
| Tersera Therapeutics LLC | 2 | $28 |
| Incyte Corporation | 2 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Seagen Inc. | 1 | $20 |
| Novartis | 1 | $17 |
| Fortovia Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| AbbVie | 1 | $12 |
| Lexicon Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QT Scanner Model 2000A$25,257
How this compares
$26,168 in reported general payments places this provider in the 90th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 16 | $286 |
| Mometasone Furoate | 18 | $274 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Statesville
- Andrew WangChapel Hill$118K
- Volker StieberWinston Salem$99K
- Lewis SulmanDurham$54K
- Michael PapagikosWilmington$51K
- William LeeDurham$37K
- Matthew ManningGreensboro$33K
- Michael ChanWinston Salem$32K
- John KirkpatrickDurham$29K
- John HeinzerlingCharlotte$29K
- Brian CzitoDurham$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.